Buyout distribution refers to obtaining the exclusive distribution rights for innovative drugs or medical devices from Ireland in China through direct investment. Simply put, enterprises are not just acting as intermediaries; instead, they gain exclusive sales rights for these innovative medical products in the Chinese market through capital investment. This ensures their unique advantage in market competition and lays the foundation for subsequent commercialization.